Zobrazeno 1 - 9
of 9
pro vyhledávání: '"J E, Joire"'
Publikováno v:
Annales de cardiologie et d'angeiologie. 48(3)
Diltiazem is an antihypertensive belonging to the class of heart rate-slowing calcium channel blockers; its antihypertensive efficacy has been demonstrated for a long time. Controlled trials have also demonstrated that it does not interfere with lipi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::846ab9f62315bc6d5c0d95c80b5c1078
https://pubmed.ncbi.nlm.nih.gov/12555384
https://pubmed.ncbi.nlm.nih.gov/12555384
Publikováno v:
Annales de cardiologie et d'angeiologie. 48(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::063bd11a05f94f37181acd3f55dd519b
https://pubmed.ncbi.nlm.nih.gov/12555361
https://pubmed.ncbi.nlm.nih.gov/12555361
Publikováno v:
Headache. 37(7)
The combination of lysine acetylsalicylate and metoclopramide is effective in the treatment of migraine attacks. It was unknown whether repeated doses could improve efficacy. The aim of this open trial was to evaluate the effects of a second, and eve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::426d869f294a4475940609f4e321837c
https://pubmed.ncbi.nlm.nih.gov/9277030
https://pubmed.ncbi.nlm.nih.gov/9277030
Publikováno v:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 4(6)
This paper describes the psychometric properties of the French version of the APQLQ (Angina Pectoris Quality of Life Questionnaire), that is to say, scaling assumptions, reliability and validity. This disease-specific Swedish questionnaire provides a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b555676b6d294147ee902d63fd74f35
https://pubmed.ncbi.nlm.nih.gov/8556014
https://pubmed.ncbi.nlm.nih.gov/8556014
Publikováno v:
European heart journal. 16(11)
Angina pectoris impairs patients' quality of life. In order to assess its impact on quality of life, a questionnaire was developed using a literature review and interviews with patients and clinicians. It consisted of a general profile (SF-36) which
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bfec6e78aaa9ecd6722cf6ff62668d6
https://pubmed.ncbi.nlm.nih.gov/8881847
https://pubmed.ncbi.nlm.nih.gov/8881847
Publikováno v:
Annales pharmaceutiques francaises. 45(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::734e5ddb1fbfa1fa01fe76fb9e617b8e
https://pubmed.ncbi.nlm.nih.gov/2893573
https://pubmed.ncbi.nlm.nih.gov/2893573
Publikováno v:
La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris. 55(39-40)
Sotalol is a new beta-adrenoceptor blocking drug without membrane stabilizing activity, without intrinsic sympathomimetic activity and with a low cardio-depressive effect. This beta-blocking agent has an half-life much longer than the other beta-bloc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::78a44f948b616051b78a96446673284f
https://pubmed.ncbi.nlm.nih.gov/232780
https://pubmed.ncbi.nlm.nih.gov/232780
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.